Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Exploratory Grants in Cancer Control (R21 Clinical Trial…

U.S. National Institutes of Health·United States of America

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028$200k – $1MGrants Notice
Get bids like this by emailBid source

Description

The National Institutes of Health (NIH) is seeking exploratory/developmental research grant applications that focus on different aspects of cancer control, including modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer. The goal is to provide support for the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research. Some key areas of focus include: • Developing novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research • Understanding etiologic factors contributing to the development of cancer • Modifying behavior to control cancer • Screening for cancer The NIH is looking for applications from eligible organizations, including nonprofits, institutions of higher education, and small businesses.

Attached files

Contact

[email protected]

(301) 402-2541

Key dates

Opened
11/12/2024
Closes
9/7/2028

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
PA-25-253

Budget estimate

$200,000 – $1,000,000

The budget for this grant is not explicitly stated, but based on the NIH's typical funding ranges for R21 grants, it is likely to be around $200,000 to $500,000 per year for up to two years. The actual budget will depend on the specific proposal, the qualifications of the applicant, and the availability of funds. Factors that may influence the likely payment range include the scope of the research, the number of personnel involved, and the equipment and resources required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 90%

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

90% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

89% match

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

88% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

U.S. National Institutes of Health·United States of America

88% match

Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/21/2023

U.S. National Institutes of Health·United States of America

88% match

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 1/11/2022

U.S. National Institutes of Health·United States of America

87% match

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/29/2023

U.S. National Institutes of Health·United States of America

87% match

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/21/2023

U.S. National Institutes of Health·United States of America

86% match

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Closes 1/7/2027Opened 12/15/2023

U.S. National Institutes of Health·United States of America

86% match

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Closes 1/7/2028Opened 1/11/2022

U.S. National Institutes of Health·United States of America

86% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

86% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

86% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

86% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

85% match

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

Closes 11/18/2026Opened 10/30/2023

U.S. National Institutes of Health·United States of America

85% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024

U.S. National Institutes of Health·United States of America

85% match

NIH Research Project Grant (Parent R01 Clinical Trial Required)

Closes 1/7/2028Opened 12/18/2024

U.S. National Institutes of Health·United States of America

85% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

85% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

85% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

84% match

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Closes 1/24/2027Opened 3/10/2026

U.S. National Institutes of Health·United States of America

84% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

84% match

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Closes 1/7/2027Opened 4/19/2023

U.S. National Institutes of Health·United States of America

84% match

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

84% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025